CH628623A5 - Process for the preparation of N-aryl-N-(4-piperidinyl)arylacetamides - Google Patents

Process for the preparation of N-aryl-N-(4-piperidinyl)arylacetamides Download PDF

Info

Publication number
CH628623A5
CH628623A5 CH1194876A CH1194876A CH628623A5 CH 628623 A5 CH628623 A5 CH 628623A5 CH 1194876 A CH1194876 A CH 1194876A CH 1194876 A CH1194876 A CH 1194876A CH 628623 A5 CH628623 A5 CH 628623A5
Authority
CH
Switzerland
Prior art keywords
group
parts
formula
piperidinyl
acid
Prior art date
Application number
CH1194876A
Other languages
German (de)
English (en)
Inventor
Stefan Sanczuk
Hubert K Fr Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CH628623A5 publication Critical patent/CH628623A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1194876A 1975-09-23 1976-09-21 Process for the preparation of N-aryl-N-(4-piperidinyl)arylacetamides CH628623A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (1)

Publication Number Publication Date
CH628623A5 true CH628623A5 (en) 1982-03-15

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1194876A CH628623A5 (en) 1975-09-23 1976-09-21 Process for the preparation of N-aryl-N-(4-piperidinyl)arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (enrdf_load_html_response)
AT (1) AT363935B (enrdf_load_html_response)
AU (1) AU510029B2 (enrdf_load_html_response)
BG (1) BG27543A3 (enrdf_load_html_response)
CA (1) CA1068271A (enrdf_load_html_response)
CH (1) CH628623A5 (enrdf_load_html_response)
CS (1) CS222663B2 (enrdf_load_html_response)
DE (1) DE2642856A1 (enrdf_load_html_response)
DK (1) DK150478C (enrdf_load_html_response)
ES (1) ES451768A1 (enrdf_load_html_response)
FI (1) FI61482C (enrdf_load_html_response)
FR (1) FR2325377A1 (enrdf_load_html_response)
GB (1) GB1539473A (enrdf_load_html_response)
GR (1) GR58469B (enrdf_load_html_response)
HU (1) HU172964B (enrdf_load_html_response)
IE (1) IE43802B1 (enrdf_load_html_response)
IL (1) IL50522A (enrdf_load_html_response)
IT (1) IT1073893B (enrdf_load_html_response)
LU (1) LU75837A1 (enrdf_load_html_response)
NL (1) NL187267C (enrdf_load_html_response)
NO (1) NO147672C (enrdf_load_html_response)
NZ (1) NZ181972A (enrdf_load_html_response)
PH (1) PH12497A (enrdf_load_html_response)
PL (2) PL192578A1 (enrdf_load_html_response)
PT (1) PT65631B (enrdf_load_html_response)
RO (1) RO70079A (enrdf_load_html_response)
SE (1) SE427839B (enrdf_load_html_response)
SU (1) SU747424A3 (enrdf_load_html_response)
YU (1) YU39973B (enrdf_load_html_response)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (ja) * 1986-05-08 1987-11-13 株式会社ヘキトク 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
KR101506156B1 (ko) 2007-04-23 2015-03-26 얀센 파마슈티카 엔.브이. 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸
HRP20120913T1 (hr) 2007-04-23 2012-12-31 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajuä†i antagonisti dopamin 2 receptora
JP2010525013A (ja) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体
AU2009266001B2 (en) 2008-07-03 2014-03-27 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-HT6 receptor antagonists
CN102171189B (zh) 2008-07-31 2013-11-20 詹森药业有限公司 作为快速解离多巴胺2受体拮抗剂的哌嗪-1-基-三氟甲基取代的吡啶
CN118496638B (zh) * 2024-07-22 2024-11-22 海安浩驰科技有限公司 一种抗紫外车窗膜及其制备方法

Also Published As

Publication number Publication date
CS222663B2 (en) 1983-07-29
IL50522A0 (en) 1976-11-30
DE2642856C2 (enrdf_load_html_response) 1990-06-21
NO763054L (no) 1977-03-24
SE427839B (sv) 1983-05-09
GR58469B (en) 1977-10-14
SU747424A3 (ru) 1980-07-23
AU510029B2 (en) 1980-06-05
DK150478B (da) 1987-03-09
NO147672C (no) 1983-05-25
PL192578A1 (pl) 1979-02-26
IL50522A (en) 1979-09-30
JPS5239683A (en) 1977-03-28
ES451768A1 (es) 1978-05-01
FI61482B (fi) 1982-04-30
SE7610501L (sv) 1977-03-24
YU39973B (en) 1985-06-30
FR2325377B1 (enrdf_load_html_response) 1980-04-18
FI762698A7 (enrdf_load_html_response) 1977-03-24
DK150478C (da) 1987-10-05
DE2642856A1 (de) 1977-03-24
IE43802B1 (en) 1981-06-03
JPS6016417B2 (ja) 1985-04-25
PL117323B1 (en) 1981-07-31
DK427876A (da) 1977-03-24
ATA702976A (de) 1981-02-15
CA1068271A (en) 1979-12-18
NL187267C (nl) 1991-08-01
PT65631A (en) 1976-10-01
LU75837A1 (enrdf_load_html_response) 1977-05-04
NO147672B (no) 1983-02-14
NZ181972A (en) 1978-07-28
NL187267B (nl) 1991-03-01
PT65631B (en) 1978-07-05
FI61482C (fi) 1982-08-10
PH12497A (en) 1979-04-05
GB1539473A (en) 1979-01-31
AU1787876A (en) 1978-03-23
AT363935B (de) 1981-09-10
RO70079A (ro) 1982-10-26
NL7610513A (nl) 1977-03-25
BG27543A3 (bg) 1979-11-12
YU233676A (en) 1983-01-21
IT1073893B (it) 1985-04-17
IE43802L (en) 1977-03-23
HU172964B (hu) 1979-01-28
FR2325377A1 (fr) 1977-04-22

Similar Documents

Publication Publication Date Title
DE2503815C2 (de) Indazol-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
CH628623A5 (en) Process for the preparation of N-aryl-N-(4-piperidinyl)arylacetamides
DE2047658A1 (enrdf_load_html_response)
DD149511A5 (de) Verfahren zur herstellung von 9-aminoalkylfluorenen
EP0110869B1 (de) Thienylessigsäureamidderivate und pharmazeutisch verträgliche Säureadditionssalze hiervon sowie Verfahren zu deren Herstellung
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
DE69803979T2 (de) Verfahren zur herstellung von carboxamido-4-azasteroiden
DE2515146A1 (de) Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3889208T2 (de) Thioformamid-Derivate.
DE2406490C2 (de) 1,4-Dihydro-3(2H)-isochinolinonverbindungen und ihre Salze, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
CH635834A5 (de) Dibenzo(d,g)(1,3,6)dioxazocin-derivate, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittelpraeparate.
DE812669C (de) Verfahren zur Herstellung von 1-Aryl-cyclopenten-(3)-1-nitrilen, deren Carbonsaeuren, deren basischen Estern und Amiden und deren Salzen
DE2943809A1 (de) 1-mercaptoacylpiperazin-2-carbonsaeure-verbindungen und ihre salze, verfahren zu ihrer herstellung und ihre verwendung bei der bekaempfung von hypertonie
DE2430510C3 (de) 16,17-Dihydroapovincaminsäureamide, Verfahren zu deren Herstellung und Arzneimittel, welche diese Verbingungen enthalten
DE2435816A1 (de) Substituierte nitrobenzophenonderivate und ihre salze sowie ihre verwendung und verfahren zur herstellung derselben
DE2720915C2 (de) N↓1↓-Acyl-2-hydroxy-1,3-diaminopropane und Arzneimittel mit diesen Verbindungen als Wirkstoff
DD151447A1 (de) Verfahren zur herstellung von amidinen und deren salzen
CH513158A (de) Verfahren zur Herstellung von Pyrrolinverbindungen
DD149664A5 (de) Verfahren zur herstellung von 1,1'-biphenyl-2-yl-alkylamin-derivaten
DE1287584B (de) Verfahren zur Herstellung von 2, 3-Dihydro-1, 4-benzoxazinderivaten
DE2166258C3 (de) Aminoalkohole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2429373A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
CH398615A (de) Verfahren zur Herstellung von neuen quaternären Piperaziniumverbindungen
DE844897C (de) Verfahren zur Herstellung von Diamidinderivaten
DE2628469B2 (de) Verfahren zur Herstellung von γ -Aminoalkoholen

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased